Telangana government is making progress with the proposed Pharma City with land acquisition in progress. Jupally Krishna Rao, Industries minister, Government of Telangana, on the sidelines of BioAsia in Hyderabad, “The government has called for tenders for Master Plan for the Pharma City. The State has acquired about 4,000 acres already and is adding more land month on month. The project is considered for NIMZ status.

Also, a medical devices park and R&D centre is also proposed at IDPL land.” Arvind Kumar, secretary, Industries, Telangana said, “Swiss firm Ferrings is keen to invest $250 million in R&D alone in Hyderabad at Genome Valley on a 10 acre land. The company will invest phase wise over the next five years. Of the 600 acre IDPL, the Medical Devices Park will come up at 260 acre and 100 acre for R&D.”

The 13th edition of BioAsia, the Biotechnology and Life-sciences forum began on Monday at Hyderabad. The 13th edition of BioAsia with the theme Connecting the dots - Leveraging India to succeed globally, is expected to witness participation of delegates from Healthcare, Biotech, Pharma, Life-Sciences, IT, Academia and Startups.

BioAsia 2016 was inaugurated by Jupally Krishna Rao, Industries minister, Telangana. Susil Premajayantha, minister of Science, Technology & Research, Sri Lanka, Nils Ragnar Kamsvag, Ambassador Designate of the Kingdom of Norway and Magdalena Cruz Yabar, minister counsellor /deputy head of Mission Embassy of Spain and Nobel Laureate professor Ada Yonath, Weismann Institute, Israel were present. Nobel Laureate Ada Yonath, Weismann Institute, Israel has been conferred the Genome Valley Excellence Award. MoUs worth Rs 1,000 crore had been signed by the industry with the State government for investing in Genome Valley.